Insulin Glargine (U-100) Cartridge Systems and Pens and Prucalopride Succinate
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Prucalopride Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: prucalopride
Brand name: Motegrity
Synonyms: Prucalopride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Prudoxin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Prudoxin Topical
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pryflex
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pseudodine C
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pseudoephedrine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pseudoephedrine and Codeine
- Prucalopride Succinate-Insulin Glargine (U-100) Vials
- Prucalopride Succinate-Insulin Glargine (U-300) Pens
- Prucalopride Succinate-Insulin glargine and lixisenatide
- Prucalopride Succinate-Insulin glargine and lixisenatide Subcutaneous
- Prucalopride Succinate-Insulin glargine, recombinant Subcutaneous
- Prucalopride Succinate-Insulin glulisine